Author Correction: Development of spirulina for the manufacture and oral delivery of protein therapeutics

Affiliations

• ¹ Lumen Bioscience, Seattle, WA, USA.
• ² Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland.
• ³ Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, VA, USA.
• ⁴ Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA.
• ⁵ Merck & Co., West Point, PA, USA.
• ⁶ Sandia National Laboratories, Livermore, CA, USA.
• ⁷ TScan Therapeutics, Waltham, MA, USA.
• ⁸ Lumen Bioscience, Seattle, WA, USA. jroberts@lumen.bio.